Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis. (2022)
Attributed to:
Development and practical application of landmarking in studies of time-varying exposures and survival
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/aje/kwab263
PubMed Identifier: 34753177
Publication URI: http://europepmc.org/abstract/MED/34753177
Type: Journal Article/Review
Volume: 191
Parent Publication: American journal of epidemiology
Issue: 3
ISSN: 0002-9262